Core Viewpoint - The stock of药捷安康-B (02617) has dropped over 14% following the unlocking of cornerstone lock-up shares on December 23, leading to a significant decline in its market value [1] Group 1: Stock Performance - As of the report, the stock price of药捷安康-B is down 14.05%, trading at 145 HKD, with a transaction volume of 163 million HKD [1] - The stock reached a historical high of 679.5 HKD per share in mid-September, representing an increase of nearly 51 times from its initial public offering price of 13.15 HKD on June 23 [1] Group 2: Share Unlocking - A total of 5 shareholders of药捷安康 experienced a share unlocking event, with a cumulative total of 9.774 million shares being released [1] - The unlocking of shares is a significant event as it may impact the stock's liquidity and market perception [1]
药捷安康-B跌超14% 今日迎基石解禁 累计解禁股数达977.4万股